Company intelligence / Profile preview

Temedica

Munich, Bavaria, Germanytemedica.com ↗

Ownership: Private
Development stage: Commercial

Overview

Temedica has developed a robust ecosystem combining insurance, sales, patient experience, and patient-reported data to generate actionable insights for healthcare providers, researchers, pharma and biotech companies. Their Permea platform is commercially available. They have launched multiple digital companion apps in partnership with major pharma companies for indications such as multiple sclerosis and psoriasis.

Therapeutic areas: DermatologyEndocrinologyNeurologyWomen's Health
Modalities: Non-pharmacological therapy (Digital companion apps, data platforms)Device (Digital health tools)
Industry: Digital Health Medical Devices

Partnerships

Roche (Brisa MS app)Bristol Myers Squibb (psoriasis app)NOVENTI Health SE (data collaboration)

Beyond the preview

Go deeper on Temedica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Temedica.

Explore the full profile